S
Spark Therapeutics
Philadelphia, United States
Founded 2013
About
Gene therapy pioneer (Luxturna) now part of Roche
Company Details
- Type
- commercial
- Employees
- 500+
- Funding
- $4.8B (acquired)
Key Products
- Luxturna
- Hemophilia Gene Therapy